Inmune Bio, Inc. (INMB) — DEF 14A Filings
All DEF 14A filings from Inmune Bio, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
INMB Seeks Shareholder Nod for Stock Option Repricing
— Oct 14, 2025 Risk: medium
Inmune Bio, Inc. (INMB) is holding a Special Meeting of Stockholders on November 18, 2025, to seek approval for the repricing of certain outstanding stock optio -
Inmune Bio Files Proxy Statement for May 28th Shareholder Meeting
— Apr 21, 2025 Risk: medium
Inmune Bio, Inc. filed a definitive proxy statement (DEF 14A) on April 21, 2025, for its annual meeting of stockholders scheduled for May 28, 2025. The filing d -
Inmune Bio Files Proxy Statement for July 19th Shareholder Meeting
— May 29, 2024 Risk: low
Inmune Bio, Inc. filed its definitive proxy statement on May 29, 2024, for its annual meeting of stockholders scheduled for July 19, 2024. The filing outlines t
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX